'lbe mouse skin tumor model was used to investigate whether the Ievel of DNA 8dducts and/or the rate of cell division in the epidermis are indicators of the risk of cancer formation for an individual in an outbred animal popul8tion. A high risk was considered to be reftected by 8 short latency period for the 8ppearance of 8 papilloma. Fernale NMRI mice were treated twice weekly with 2.5 nmol 7 ,12-dimethylbenz [a]antbracene (DMBA) and 3 nmoi12-0-tetradecanoylphorbol-13-8cetate (TPA) and the appearance of papillomas was registered. The first papilloma 8ppeared after 7.5 weeks. After 17 weeks, when 12 of 14 mice bad 8t least one papilloma, an osmotic minipump deliverlog 5-bromo-2'-deoxyuridine (BrdU) was implanted into eacb mouse for 24 h. The mice were killed after 24 h ~d the epidermis was analyzed for D:MBA-nucleotide 8dducts by 32p.postlabeling, for the cell number per unit skin length, and for the labeling index for DNA synthesls. Unexpectedly, D:MBA-nucleotide 8dduct Ievels were highest in those anima1s wbich showed the Iongest latency periods. Adduct Ievels were negatively correlated with the 18beling index, indicating that dilution of adducts by cell division was a predominant factor in determining average adduct concentrations. Individual tumor-latency time was not corTelated with either cell ntunber or labeling index. This could be due to the fact that the measurements only provided 8veraged data and gave no infonnation on the specific situation in clones of premalignant cells. Under the conditions of tbis assay, therefore, neither DNA adduct Ievels nor information on the average kinetics of cell division bad a predidive value for the individual amcer risk withln a group of outbred animals receiving the same treatment.
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Introducdon
The risk of an individual to develop a carcinogen-induced tumor is dependent upon heritable and Iife-style factors that detennine carcinogen metabolism leading to DNA adducts and rates ofDNA repair and cell division (1) . The question is whether one or the other of these factors could be used as a predictive marker for an individual cancer risk.
With the introduction of the 3 2 P-postlabeling method, the measurement of DNA adducts in human samples has become a routine technique for biomonitaring exposure to carcinogens (2) . Attempts to correlate adduct Ievels with cancer risk, however, have been hampered by the facts that (i) target tissue is not easily *Abbreviations: DMBA, 7,12-dimetbylbenz[a]antbracene; TPA, 12-0-tetradccanoylphorbol-13-acerat.e; BrdU, 5-bromo-2' -deoxyuridine. @ Oxford UDiversity Press available and that (ü) 'individual cancer risk' is not weil defined. One study dealt with lung cancer patients undergoing surgery: it was found that the patients who were <55 years old had a higher Ievel of DNA adducts in bronchial biopsies as compared with the >55 year-old group (3). This finding could be interpreted as if high adduct Ievels could be responsible for a short latency period. Unfortunately, smoking habits in the weeks before surgery were not reported for the two groups.
In this study, we investigated under experimental conditions whether DNA adduct Ievels andlor rates of cell division in the target tissue have a predictive value for the individual cancer risk.
The mouse skin tumor model of Heckerand coworkers (4) was used. It allows a visual observation of the appearance of papillomas. The individual tumor latency time can be used as an indicator of the individual cancer risk. The mice were treated repeatedly with 7,12-dimethylbenz[a]anthracene (D:MBA*) as a DNA adduct-forming carcinogen and 12-0-tetradecanoylphorbol-13-acetate (TPA) as a tumor-promoting agent affecting cell division and differentiation. This combined treatment was considered to best retlect chronic exposure of humans to both genotoxic and nongenotoxic carcinogens. The hypothesis was tested whether DNA adduct Ievels and/or rates of cell division are highest in those · animals where a skin papilloma is seen earliest.
Materials and methods

Chemieals
The following sources were used: DMBA, acetone and proteinase K: Fluka AG, Buchs 24 h 1ater, all mk:e were killed by an overdose of balodume. The treat.ed sldn ua and a piece of the sma'n inresdne were excised. A tumor-free part of the skin and the small intestine were prepared for the immunobistochemisUy, the remaining skin excluding papilloma was used to isolate DNA.
DNA isolalion and »p-ponfabeling
Tbe epidennis (without tumor-bearing areas) was saaped off witb a sc:alpel after brief warming of the skin to ssoc in a waterbath (S) and was stored a1 -80°C.
DNA was isolated acconling to publisbed methods (6 The cumulapve skip-:-pq»illor,na incidence of mice treated twice weeldy with DMBA.and·TPA :is shown in Figure 1 . Thefirst anilnäl. showed a papifioma alter 7.5 weekS of treatment; the 12th in codon 61 (A 1 B2) of the Ha-ras gene (11). Guanine in codon 12, on the other band, was not found to be substituted. It would be premature, however, to consider the major adduct seen in this chronic study (adduct 1) an innocuous DNA modification. In another report on carcinogen-specific mutation of Ha-ras during mouse skin carcinogenesis, a small proportion of DMBA-induced tumours were activated at codon 12, presumably by changes at one oftwoG residues (12) . Furthennore, it cannot be excluded that adducts which are not particularly strong in rtlS activation result in other types of mutations, for instance strand breaks after depurination. This discussion illustrates that the total Ievels of adducts can only represent an approximate risk marker but, on the other band, one should not regard any adduct as completely harmless.
CeU division and latency time
The rate of accumulation of mutatiorm from promutagenic DNA adducts is dependent on the number of proliferating cells and on the. rate of cell division (13, 14) . An inverse correlation between one of these variables and the papilloma-latency time could therefore be expected. The ·analysis of our data is shown in Figure 4 . Neither labeling index (A) nor cell number (B) showed any correlation with the papilloma-lalency time. Although the labeling index varied more than threefold within the group of mice under analysis, the individual response of the normal epidennis to the mitogenic activity of TP A did not correlate with the rate of papilloma fonnation.
Cell division and DNA adducts
The concentration of DNA adducts is dependent on the rates of fonnation and repair, and on the rate of dilution by DNA synthesis. With each round of DNA replication, the adduct concentration is divided in half because the newly synthesized strand does not contain adducts. The higher the rate of cell division, therefore, the 1ower the adduct concentration measured in the isolated DNA. This phenomenon could indeed be seen in ihis study and is illustraled in Figure S : the concentration of adduct 1 was lowest in those individuals that showed the highest labeling index (P = 0.02, Speannan rank correlation coeflicient test). This could also explain the unexpected correlation between low adduct Ievels and shon tumor latency period: individuals with high susceptibility to the mitogenic activity of TP A are expected to show a lower average Ievel of DNA adducts.
CeU type specificity
The question remains why the individual tumor latency was not correlated with any of our data on cell division. The problem could have its roots in the fact that both the rates of DNA replication and the numbers of cells 'at risk' were determined without accounting for the cell type, for the Status of the cells in the multi-stage process of carcinogenesis, and for the question 1287 whether the cells have the ability to replicate. Information on the cell division kinetics in premalignant clones of cells might be required for such a correlation to become apparent. Biomonitoring and molecular epidemiology Our da1a could have important consequences for the interpretation of results from biomonitaring human exposure to carcinogens by measuring DNA adduct Ievels. In such studies, it is very tempting to use DNA adduct Ievels not only as an exposure marker but also to interpret individual differences in tenns of different individual cancer risks. Our data indicate, however, that adduct Ievels measured in a target tissue could even be negatively correlated with the individual risk for cancer development, probably because of differences in the rate of cell division acting as a confounding factor.
Our data are strictly valid only for the skin-papilloma model used with repeated administration of both initiating and promoting agents and should be extrapolated to other situations with caution. On the other band, most human biomonitaring studies are based on DNA from peripheral lymphocytes which rarely represent target cells. It is concluded that DNA adduct Ievels measured in human samples are unlikely tobe of a general predictive value for an individual cancer risk.
